Department of Translational Medical Science, section of Pediatrics, University of Naples Federico II, 80131 Naples, Italy. fabiola.didato@unina.it., Italian Society of Pediatric Gastroenterology and Nutrition (SIGENP), 20126 Milan, Italy. fabiola.didato@unina.it., Department of Translational Medical Science, section of Pediatrics, University of Naples Federico II, 80131 Naples, Italy. s.spadarella@gmail.com., Great Ormond Street Hospital for Children NHS Foundation Trust, Great Ormond St, Holborn, London WC1N 3JH, UK. giovanna.puoti@hotmail.it., Institute of Biostructure and Bioimaging National Research Council, 80145 Naples, Italy. mariagrazia.caprio@ibb.cnr.it., Department of Pediatrics and Public Health and Pediatric Sciences, University of Torino, 10126 Torino, Italy. pagliardini.severo@virgilio.it., Department of Translational Medical Science, section of Pediatrics, University of Naples Federico II, 80131 Naples, Italy. claudiazuppaldi@libero.it., Pediatric Radiology, Department of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy. gianfranco.vallone1@gmail.com., Department of Translational Medical Science, section of Pediatrics, University of Naples Federico II, 80131 Naples, Italy. simona.fecarotta@gmail.com., Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy. gabriella.esposito@unina.it., CEINGE Advanced Biotechnologies, 80145 Naples, Italy. gabriella.esposito@unina.it., Department of Translational Medical Science, section of Pediatrics, University of Naples Federico II, 80131 Naples, Italy. riorio@unina.it., Italian Society of Pediatric Gastroenterology and Nutrition (SIGENP), 20126 Milan, Italy. riorio@unina.it., Department of Translational Medical Science, section of Pediatrics, University of Naples Federico II, 80131 Naples, Italy. parenti@unina.it., Telethon Institute of Genetics and Medicine, 80078 Pozzuoli, Italy. parenti@unina.it., Department of Translational Medical Science, section of Pediatrics, U
References: Not available.
Daily Fructose Traces Intake and Liver Injury in Children with Hereditary Fructose Intolerance
BACKGROUND: Hereditary fructose intolerance (HFI) is a rare genetic disorder of fructose metabolism due to aldolase B enzyme deficiency. Treatment consists of fructose, sorbitol, and sucrose (FSS)-free diet. We explore possible correlations between daily fructose traces intake and liver injury biomarkers on a long-term period, in a cohort of young patients affected by HFI. METHODS: Patients' clinical data and fructose daily intake were retrospectively collected. Correlations among fructose intake, serum alanine aminotransferase (ALT) level, carbohydrate-deficient transferrin (CDT) percentage, liver ultrasonography, genotype were analyzed. RESULTS: We included 48 patients whose mean follow-up was 10.3 +/- 5.6 years and fructose intake 169 +/- 145.4 mg/day. Eighteen patients had persistently high ALT level, nine had abnormal CDT profile, 45 had signs of liver steatosis. Fructose intake did not correlate with ALT level nor with steatosis severity, whereas it correlated with disialotransferrin percentage (R(2) 0.7, p < 0.0001) and tetrasialotransferrin/disialotransferrin ratio (R(2) 0.5, p = 0.0001). p.A150P homozygous patients had lower ALT values at diagnosis than p.A175D variant homozygotes cases (58 +/- 55 IU/L vs. 143 +/- 90 IU/L, p = 0.01). CONCLUSION: A group of HFI patients on FSS-free diet presented persistent mild hypertransaminasemia which did not correlate with fructose intake. Genotypes may influence serum liver enzyme levels. CDT profile represents a good marker to assess FSS intake.
Daily Fructose Traces Intake and Liver Injury in Children with Hereditary Fructose Intolerance
No results.
Daily Fructose Traces Intake and Liver Injury in Children with Hereditary Fructose Intolerance
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(549 views) N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 ViewExport to BibTeXExport to EndNote